No verified executable Anduril opportunity was found.
The latest completed financing is the $5 billion Series H at a $61 billion valuation. Public models range from $60 to $140 per share, but their methods, dates, securities and execution status differ. They cannot be averaged into a defensible market price.
What the evidence actually supports
- Series H closed May 13, 2026: $5B raised at a reported $61B valuation.
- Reported values near $100B and a conditional $110B remain financing talks, not completed transactions.
- Filed fund marks are accounting observations. The research package found roughly $40.88-$96.71 across different dates and securities; none is a trade.
- The Army's $20B IDIQ is a maximum ceiling. It is not $20B of funding, backlog or revenue.
Four prices, four evidence boundaries
| Source | Price | As of |
|---|---|---|
| Hiive | $60.00 | Aug 2 |
| NPM | $116.17 | Jul 20 |
| Notice | $117.34 | Aug 4 |
| Forge | $140.00 | Aug 4 |
These are source-published models or indications. Dark Floors verified no public ask, bid or completed secondary instrument behind them.
Where public data breaks
- Notice displays $117.34 and $103.81B, then says Anduril is not currently traded, lacks price-history data and has raised $0 across 0 rounds.
- Forge publishes a Series G-1 row that the research could not corroborate with an issuer announcement or public filing.
- Forge's expanded round table contains a misleading share field; it is excluded from cap-table inference.
- Potential overlap between Marine Corps counter-UAS awards remains unresolved to prevent double counting.
Dark Floors, Anduril Private-Market Evidence Archive, version 1.0.0, data through August 4, 2026.